{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:50:37Z","timestamp":1769147437564,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.mehy.2017.10.025","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T21:35:32Z","timestamp":1509831332000},"page":"68-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Betacaryophyllene \u2013 A phytocannabinoid as potential therapeutic modality for human sepsis?"],"prefix":"10.1016","volume":"110","author":[{"given":"Angel","family":"Meza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mehy.2017.10.025_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"62","key":"10.1016\/j.mehy.2017.10.025_b0010","first-page":"1","article-title":"Inpatient care for septicemia or sepsis: a challenge for patients and hospitals","volume":"62","author":"Hall","year":"2011","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0015","first-page":"1","article-title":"STATISTICAL BRIEF # 160 National Inpatient Hospital Costs : the Most. Healthc Cost Util Proj Stat Br #160","volume":"31","author":"Torio","year":"2013","journal-title":"Natl Inpatient Hosp Costs Most Expens Cond by Payer"},{"key":"10.1016\/j.mehy.2017.10.025_b0020","doi-asserted-by":"crossref","unstructured":"Kelly MEM, Lehmann C, Zhou J. The Endocannabinoid System in Local and Systemic Inflammation. Colloquium. (Granger DN, Granger JP. eds.). Morgan & Claypool series; 2017.","DOI":"10.4199\/C00151ED1V01Y201702ISP074"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.025_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10.1016\/j.mehy.2017.10.025_b0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB 1 and CB 2 Receptor Signaling and Bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1471-4892(01)00120-5","article-title":"Cannabinoids: a real prospect for pain relief?","volume":"2","author":"Iversen","year":"2002","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.025_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0163-7258(02)00258-9","article-title":"Cardiovascular effects of cannabinoids","volume":"95","author":"Randall","year":"2002","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/13543784.12.1.39","article-title":"Cannabinoids for gastrointestinal diseases: potential therapeutic applications","volume":"12","author":"Di Carlo","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"10.1016\/j.mehy.2017.10.025_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00210-003-0787-3","article-title":"Analysis of the respiratory effects of cannabinoids in rats","volume":"368","author":"Schmid","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur J Biochem"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2017.10.025_b0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1054\/plef.2001.0355","article-title":"Endocannabinoids in the immune system and cancer","volume":"66","author":"Parolaro","year":"2002","journal-title":"Prostaglandins, Leukot Essent Fat Acids"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","article-title":"The cannabinoid receptor 2 is critical for the host response to sepsis","volume":"183","author":"Tschop","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.mehy.2017.10.025_b0080","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.mehy.2017.10.025_b0085","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1006\/nbdi.1998.0221","article-title":"Endogenous cannabinoid signaling","volume":"5","author":"Piomelli","year":"1998","journal-title":"Neurobiol Dis"},{"issue":"6644","key":"10.1016\/j.mehy.2017.10.025_b0090","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2017.10.025_b0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(98)00314-1","article-title":"Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors","volume":"57","author":"Goparaju","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12248-009-9084-5","article-title":"Cannabinoids, endocannabinoids, and related analogs in inflammation","volume":"11","author":"Burstein","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.mehy.2017.10.025_b0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1054\/plef.2001.0348","article-title":"Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function","volume":"66","author":"Schmid","year":"2002","journal-title":"Prostaglandins, Leukot Essent Fat Acids"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.025_b0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acs.chemrev.5b00411","article-title":"medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2 receptor agonists","volume":"116","author":"Aghazadeh Tabrizi","year":"2016","journal-title":"Chem Rev"},{"issue":"8","key":"10.1016\/j.mehy.2017.10.025_b0115","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mehy.2017.10.025_b0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0028-1097829","article-title":"The essential oil of cannabis sativa","volume":"28","author":"Malingre","year":"1975","journal-title":"Planta Med"},{"issue":"c","key":"10.1016\/j.mehy.2017.10.025_b0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1515\/znc-2010-9-1009","article-title":"Antibacterial activity of the essential oil from rosmarinus offi cinalis and its major components against oral pathogens","volume":"65","author":"Bernardes","year":"2010","journal-title":"Z Naturforsch C"},{"key":"10.1016\/j.mehy.2017.10.025_b0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0031-9422(00)00474-X","article-title":"The essential oil of Origanum vulgare L. ssp. vulgare growing wild in Vilnius district (Lithuania)","volume":"57","author":"Mockute","year":"2001","journal-title":"Phytochemistry"},{"key":"10.1016\/j.mehy.2017.10.025_b0135","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1021\/jf034169i","article-title":"Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant activities","volume":"51","author":"Agan","year":"2003","journal-title":"Agric Food Chem"},{"key":"10.1016\/j.mehy.2017.10.025_b0140","first-page":"2582","article-title":"Effect of storage on the essential oil composition of piper nigrum L. Fruits of different ripening states","author":"Orav","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.mehy.2017.10.025_b0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/np50085a029","article-title":"Sesquiterpenes from Clove (Eugenia caryophyllata) as Potential Anticarcinogenic Agents","volume":"7","author":"Zheng","year":"1992","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.025_b0150","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc11248","article-title":"Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis","volume":"16","author":"Lehmann","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.mehy.2017.10.025_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/978678","article-title":"Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis","volume":"2014","author":"Sardinha","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mehy.2017.10.025_b0160","first-page":"1","article-title":"Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells","author":"Yang","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.025_b0165","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11481-015-9591-3","article-title":"Activation of cannabinoid type two receptors (CB2) diminish inflammatory responses in macrophages and brain endothelium","volume":"10","author":"Persidsky","year":"2016","journal-title":"Neuroimmune Pharmacol"},{"key":"10.1016\/j.mehy.2017.10.025_b0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.febslet.2005.12.079","article-title":"Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kB pathway inhibition","volume":"580","author":"Nakajima","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2017.10.025_b0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abio.2001.5015","article-title":"Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis : increase in endogenous cannabinoids in the sera of patients with endotoxic shock","volume":"294","author":"Wang","year":"2001","journal-title":"Anal Biochem"},{"issue":"5","key":"10.1016\/j.mehy.2017.10.025_b0180","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1744-9987.2008.00612.x","article-title":"Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock","volume":"12","author":"Kase","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"2","key":"10.1016\/j.mehy.2017.10.025_b0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cpt.563","article-title":"Focus on cannabinoids and synthetic cannabinoids","volume":"101","author":"Le Boisselier","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mehy.2017.10.025_b0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0310057X0403200420","article-title":"Reductions in levels of bacterial superantigens\/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome","volume":"32","author":"Kohro","year":"2004","journal-title":"Anaesth Intensive Care"},{"issue":"26","key":"10.1016\/j.mehy.2017.10.025_b0195","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.mehy.2017.10.025_b0200","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.lfs.2006.11.038","article-title":"Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of \u03b2-caryophyllene, a sesquiterpene","volume":"80","author":"Cho","year":"2007","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.mehy.2017.10.025_b0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-2006-957942","article-title":"Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, ??-caryophyllene","volume":"62","author":"Tambe","year":"1996","journal-title":"Planta Med"},{"key":"10.1016\/j.mehy.2017.10.025_b0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1099-1573(199605)10:3<238::AID-PTR830>3.0.CO;2-S","article-title":"Volatile antiallergic principles from a traditional herbal prescription of kampo medicine","volume":"10","author":"Tanaka","year":"1996","journal-title":"Phyther Res"},{"key":"10.1016\/j.mehy.2017.10.025_b0215","article-title":"Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil","volume":"261\u2013269","author":"Cornwell","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mehy.2017.10.025_b0220","article-title":"Physicochemical characterization and pharmacokinetics evaluation of \u03b2-caryophyllene\/\u03b2-cyclodextrin inclusion complex","volume":"1\u20137","author":"Liu","year":"2013","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.mehy.2017.10.025_b0225","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","article-title":"The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","volume":"24","author":"Klauke","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"10.1016\/j.mehy.2017.10.025_b0230","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00011-016-0969-3","article-title":"The cannabinoid 2 receptor agonist \u03b2-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration","volume":"65","author":"Andrade-Silva","year":"2016","journal-title":"Inflamm Res"},{"key":"10.1016\/j.mehy.2017.10.025_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.physbeh.2014.06.003","article-title":"\u0392-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice","volume":"135","author":"Bahi","year":"2014","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.mehy.2017.10.025_b0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-016-2733-y","article-title":"B -Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease","volume":"418","author":"Ojha","year":"2016","journal-title":"Mol Cell Biochem"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717308617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717308617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T21:42:00Z","timestamp":1750974120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717308617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"alternative-id":["S0306987717308617"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.10.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Betacaryophyllene \u2013 A phytocannabinoid as potential therapeutic modality for human sepsis?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}